Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Celera CORP | 15,553,417 | reported | 09 May 2011 | tx 13+1,757,200 |
| AVIGEN INC \DE | 7,837,189 | reported | 18 Nov 2009 | tx 1−626 |
| ARRAY BIOPHARMA INC | 7,058,997 | reported | 01 Jul 2014 | tx 1−494,092 |
| ARQULE INC | 4,811,073 | reported | 01 Apr 2010 | tx 6−3,753,000 |
| Oncothyreon Inc. | 4,758,891 | reported | 08 Aug 2013 | tx 2+258,361 |
| Calithera Biosciences, Inc. | 4,739,356 | reported | 20 Nov 2019 | tx 6+320,442 |
| ARENA PHARMACEUTICALS INC | 4,520,212 | reported | 17 Oct 2003 | tx 1−2,911,000 |
| ADOLOR CORP | 4,289,551 | reported | 22 Sept 2009 | tx 6−354,000 |
| ORTHOLOGIC CORP | 3,993,637 | reported | 01 Jul 2014 | tx 13+690,100−616,563 |
| FACET BIOTECH CORP | 3,900,870 | reported | 04 Feb 2010 | tx 9+156,749 |
5 purchases reported after at least 12 months of silence — most recent on 16 Mar 2021.
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 15 Jun 2023 | GRANT_AWARD | Kymera Therapeutics, Inc. | 12,000 | 0.00 USD | deriv |
| 09 Aug 2022 | SALE | CELL THERAPEUTICS INC | 3,850,803 | 6.12 USD | |
| 09 Aug 2022 | SALE | CELL THERAPEUTICS INC | 2,890,723 | 6.12 USD | |
| 09 Aug 2022 | CONVERSION | CELL THERAPEUTICS INC | 1,519,999 | — | |
| 09 Aug 2022 | SALE | CELL THERAPEUTICS INC | 1,289,434 | 6.12 USD | |
| 09 Aug 2022 | CONVERSION | CELL THERAPEUTICS INC | 682,666 | — | |
| 09 Aug 2022 | SALE | CELL THERAPEUTICS INC | 469,040 | 6.12 USD | |
| 09 Aug 2022 | CONVERSION | CELL THERAPEUTICS INC | 2,426,666 | — | |
| 09 Aug 2022 | CONVERSION | CELL THERAPEUTICS INC | 3,754,000 | — | |
| 09 Aug 2022 | CONVERSION | CELL THERAPEUTICS INC | 2,280 | — | deriv |
| 09 Aug 2022 | CONVERSION | CELL THERAPEUTICS INC | 1,024 | — | deriv |
| 09 Aug 2022 | CONVERSION | CELL THERAPEUTICS INC | 3,640 | — | deriv |
| 09 Aug 2022 | CONVERSION | CELL THERAPEUTICS INC | 5,631 | — | deriv |
| 23 Apr 2021 | CONVERSION | Rain Therapeutics Inc. | 152,176 | — | |
| 23 Apr 2021 | CONVERSION | Rain Therapeutics Inc. | 134,515 | — | |
| 23 Apr 2021 | CONVERSION | Rain Therapeutics Inc. | 115,293 | — | |
| 23 Apr 2021 | GRANT_AWARD | Rain Therapeutics Inc. | 546,346 | 17.00 USD | |
| 23 Apr 2021 | GRANT_AWARD | Rain Therapeutics Inc. | 53,303 | 15.93 USD | |
| 26 Apr 2021 | GRANT_AWARD | Rain Therapeutics Inc. | 14,790 | 14.90 USD | |
| 23 Apr 2021 | CONVERSION | Rain Therapeutics Inc. | 832,261 | — | |
| 23 Apr 2021 | GRANT_AWARD | Rain Therapeutics Inc. | 6,141 | 15.93 USD | |
| 23 Apr 2021 | GRANT_AWARD | Rain Therapeutics Inc. | 62,948 | 17.00 USD | |
| 23 Apr 2021 | CONVERSION | Rain Therapeutics Inc. | 17,390 | — | |
| 23 Apr 2021 | CONVERSION | Rain Therapeutics Inc. | 837,397 | — | |
| 23 Apr 2021 | CONVERSION | Rain Therapeutics Inc. | 553,359 | — |